Trazodone for Pain and Sleep: Dual-Purpose Prescribing in PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 29, 2026 | 9 min read

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) prescribed at low doses for insomnia and at higher doses for depression, with emerging evidence supporting its role in chronic pain modulation. When prescribed after a traumatic injury, trazodone's dual-purpose action documents two distinct injury domains -- sleep disruption and pain -- with a single medication, strengthening the multi-system damage narrative.

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) that serves a dual therapeutic role in personal injury cases: sleep restoration at low doses (25-100 mg) and mood/pain modulation at higher doses (150-300 mg). This dual-purpose pharmacology means a single trazodone prescription documents two distinct injury domains -- chronic sleep disruption and pain or mood disturbance -- making it uniquely valuable for demonstrating the multi-system impact of traumatic injuries.

• Trazodone at low doses (25-100 mg) treats injury-related insomnia through serotonin 5-HT2A antagonism and histamine blockade
• At higher doses (150-300 mg), trazodone provides antidepressant and pain-modulating effects through serotonin reuptake inhibition
• A single prescription documents both sleep disruption and pain/mood disturbance, supporting multi-domain injury claims
• LienScripts covers trazodone under a pharmacy lien at zero upfront cost throughout the case
• Dose escalation from sleep doses to antidepressant doses documents worsening psychological injury

Why Dual-Purpose Prescribing Matters for PI Cases

In personal injury litigation, each medication in the patient's regimen documents a specific injury-related condition. Dual-purpose medications like trazodone are strategically important because they demonstrate that a single injury produced multiple functional impairments requiring pharmacological intervention.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains: "Trazodone is one of the most informative medications in a post-injury pharmacy record. At 50 mg at bedtime, it tells me the patient cannot sleep due to the injury. At 150 mg, it tells me the patient is now dealing with depression or chronic pain on top of the insomnia. That dose escalation from sleep to antidepressant range documents the injury's expanding impact on the patient's life."

Trazodone for Post-Injury Insomnia

Mechanism at Sleep Doses

At 25-100 mg, trazodone promotes sleep primarily through:

• 5-HT2A receptor antagonism: Blocks the serotonin receptor subtype that promotes wakefulness
• Histamine H1 receptor antagonism: Produces sedation without the dependence risk of benzodiazepines or Z-drugs
• Alpha-1 adrenergic blockade: Reduces sympathetic arousal that interferes with sleep onset

This mechanism is distinctly different from benzodiazepines (GABA enhancement) and Z-drugs (selective GABA-A modulation), making trazodone a preferred option for patients who need long-term sleep support without controlled substance concerns.

[!KEY] Trazodone's non-controlled status allows indefinite prescribing for chronic insomnia. Unlike zolpidem or temazepam, which raise dependence concerns and prescribing limitations, trazodone can be refilled continuously, generating an unbroken pharmacy record documenting persistent sleep disruption.

Standard Sleep Dosing Protocol

• Week 1: 25-50 mg at bedtime
• Week 2-4: Titrate to 50-100 mg based on response
• Maintenance: 50-100 mg nightly for the duration of sleep disruption

Trazodone for Pain Modulation

At higher doses, trazodone's serotonin reuptake inhibition provides analgesia through descending serotonergic pain pathways. While not as potent as dedicated analgesics, this pain-modulating effect is clinically meaningful for:

• Chronic musculoskeletal pain that interferes with sleep
• Centralized pain conditions that develop after prolonged injury
• Headache conditions, particularly tension-type and post-concussive headaches

The transition from sleep-dose to antidepressant/analgesic-dose trazodone documents the expansion of the injury's impact beyond sleep into pain and mood domains.

Documentation Value: Dose Escalation Narrative

[!TIP] Present trazodone dose escalation as a progressive injury narrative in the demand package: "The patient initially required trazodone 50 mg solely for injury-related insomnia. Three months later, the dose was increased to 150 mg as the patient developed persistent depressive symptoms and worsening pain, demonstrating that the injury's psychological and functional impact continued to expand rather than resolve."

The trazodone dosing timeline creates a documentary arc:

1. Month 1-2: Low-dose trazodone (50 mg) documents acute sleep disruption
2. Month 3-6: Dose increase to 100-150 mg documents emerging depression or persistent pain
3. Month 6-12: Maintenance at antidepressant doses documents chronic multi-domain impairment
4. Month 12+: Continued treatment documents permanent injury impact

Combination Therapy Patterns

Trazodone frequently appears alongside other injury-related medications:

• Trazodone + SSRI: Trazodone for sleep, SSRI for anxiety/PTSD -- documents both insomnia and psychiatric injury
• Trazodone + Gabapentin: Addresses sleep and neuropathic pain through complementary mechanisms
• Trazodone + Muscle Relaxant: Sleep support plus musculoskeletal injury treatment
• Trazodone + Prazosin: Trazodone for sleep onset, prazosin for PTSD nightmares -- documents multiple sleep disruption mechanisms

Each combination pattern tells the demand package reviewer which injury domains remain active.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that explains trazodone's dual-purpose role and how the dosing trajectory maps to the injury's clinical evolution.

Advantages Over Alternative Sleep Medications

Vs. Zolpidem (Ambien)

Trazodone avoids controlled substance classification, dependence risk, and complex sleep behaviors. Its non-controlled status supports long-term prescribing without the regulatory scrutiny that defense could exploit.

Vs. Benzodiazepines

No tolerance development or physiological dependence with chronic use. Trazodone can be prescribed indefinitely without escalating doses, creating consistent pharmacy documentation.

Vs. Quetiapine

Lower metabolic side-effect profile. Trazodone is a more proportionate response to insomnia, while quetiapine's use for sleep documents more severe or treatment-resistant symptoms.

Pharmacy Lien Coverage

LienScripts covers trazodone and all sleep and psychiatric medications under a pharmacy lien at zero upfront cost. Whether prescribed at sleep doses or antidepressant doses, the LienScripts platform ensures continuous medication access throughout the case.

Related Resources

• Trazodone for Sleep Disruption After Injury
• Sleep Medication Guide for Personal Injury
• Trazodone vs. Zolpidem for Sleep in PI Cases